Synergistic immunosuppressive effects of rosmarinic acid and rapamycin in vitro and in vivo

Transplantation

Volumn 75, Issue 10, 2003, Pages 1758-1760

  Yun, Su Young ^a   Hur, Yun Gyoung ^a   Sang, Mi Ae ^a   Lee, Jihyun ^a   Ahn, Curie ^b   Won, Jonghwa ^a  

^a Mogam Biotechnology Research Institute   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PREDNISONE; RAPAMYCIN; ROSMARINIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DRUG EFFICACY; DRUG POTENTIATION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL DIVISION; CINNAMATES; CYCLOSPORINE; DEPSIDES; DRUG SYNERGISM; GLUCOCORTICOIDS; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PREDNISONE; SIROLIMUS; SKIN TRANSPLANTATION; SPLEEN; T-LYMPHOCYTES;

EID: 0038689037     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000063933.12440.50     Document Type: Article

References (10)

1. Bernard A, Lamy L, Alberti I. The two-signal model of T-cell activation after 30 years. Transplantation 2002; 73: S31.
2. Allison AC. Immunosuppressive drugs: the first 50 years and a glance forward. Immunopharmacology 2000; 47: 63.
3. Eng CP, Gullo-Brown J, Chang JY, et al. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide. Transplant Proc 1991; 23: 868.
4. Stepkowski SM, Erwin-Cohen RA, Behbod F, et al. Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin. Blood 2002; 99: 680.
5. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530.
6. Englberger W, Hadding U, Etschenberg E, et al. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity. Int J Immunopharmacol 1988; 10: 729.
7. Kelm MA, Nair MG, Strasburg GM, et al. Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 2000; 7: 7.
8. al-Sereiti MR, Abu-Am KM, Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 1999; 37: 124.
9. Won J, Hur Y-G, Hur EM, et al. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner. Eur J Immunol 2003; 33: 870.
10. Kahan BD, Camardo JS. Rapamycin: clinical results and future opportunities. Transplantation 2001; 72: 1181.